 |
Publications |
|
|
Articles:
Simplicity wins – From product conceptualisation to drug delivered
Drug Delivery Report, Spring/Summer 2006.
PharmaVentures Ltd.
View article in PDF (3.5Mb)
Advanced simplification of nasal delivery: Anatomy + innovative device = added value opportunity
ONDrugDelivery, 3rd Issue, Nasal Delivery, October 2005
ONDrugDelivery Ltd.
View article in PDF (1.9Mb)
Direct-Haler AS; Emerging Company profile
Start-Up: Windhover's Review of Emerging Medical Ventures, February 2005
Windhover
Link to Windhover
Call for combined asthma and rhinitis treatment offers opportunities for drug delivery innovators.
European Pharmaceutical Contractor, Autoumn 2005.
Samedan
View article in PDF (300kb) World-wide tests: the market wants the world´s first mono-dose, single-use, disposable inhaler
Supplement to Scrip World Pharmaceutical News, October 2004
Informa Plc
View article in PDF (11.8Mb)
Second-generation respiratory combination therapy: fresh thinking brings new opportunities
Drug delivery: taking the initiative in tough times for pharma.
Supplement to Scrip World Pharmaceutical News, 2004
Informa Plc.
View article in PDF (1.1Mb)
Direct-Haler adapts pulmonary device for nasal delivery
Scrip's Target World Drug Delivery News, March 2003. Issue 15
Informa Publications
View article in PDF (900kb)
Direct-Haler: Refined thinking that could transform the pulmonary delivery market
Scrip's Target World Drug Delivery News, January 2003. Issue 13
Informa Plc
View article in PDF (80kb)
Press Releases:
Presentations:
Co-existing allergic rhinitis and allergic asthma; one airway – one disease
Transforming the new insight to patient benefit by innovation
Respiratory Drug Development 2005, Cologne, June 2005.
IIR Conferences, Life Sciences.
View presentation in PDF (900kb)
How to treat co-existing allergic rhinitis and allergic asthma: The second-generation respiratory combination therapy
Asthma Therapies 2004, London, December 2004.
Visiongain Ltd.
View presentation in PDF (1.9Mb)
Novel approaches to extend your product’s life cycle – inspiration and examples from respiratory therapy.
Generics & Patent Life Cycle Management, London, November/December 2004.
Visiongain Ltd.
View presentation in PDF (1.7Mb)
Taking the initiative in tough times for pharma – the second generation respiratory combination therapy.
Specialty Pharma, Corporate Development Global Summit, New Jersey, September 2004.
Strategic Research Institute
View presentation in PDF (1.7Mb)
Introducing the novel DirectHaler™ DPI technology and philosophy
12th Annual Conference, Dry Powder Inhalers, London, June 2003.
Management Forum Ltd.
View presentation in PDF (1Mb)
|
|
|
